![Marcelo Bravo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcelo Bravo
Chief Executive Officer at OXvax Ltd
Marcelo Bravo active positions
Companies | Position | Start | End |
---|---|---|---|
Oxford Pharmascience Ltd.
![]() Oxford Pharmascience Ltd. Pharmaceuticals: MajorHealth Technology Oxford Pharmascience Ltd. operates as a drug development firm. The company was founded on February 8, 2008 and is headquartered in London, the United Kingdom. | Director/Board Member | 08/02/2008 | - |
OXvax Ltd
![]() OXvax Ltd BiotechnologyHealth Technology OXvax Ltd is a British company that develops cancer vaccines. The company was founded in 2021 by Paul J. Fairchild, Marcelo Leonardo Bravo, Tim Davies. Marcelo Leonardo Bravo has been the CEO since 2021. | Chief Executive Officer | 15/02/2021 | - |
Founder | 15/02/2021 | - |
Career history of Marcelo Bravo
Former positions of Marcelo Bravo
Companies | Position | Start | End |
---|---|---|---|
DEEPMATTER GROUP PLC | Director/Board Member | - | 01/10/2009 |
President | - | 01/10/2009 | |
ABACO CAPITAL PLC | Founder | 07/10/2009 | - |
Training of Marcelo Bravo
The College of Wooster | Undergraduate Degree |
Case Western Reserve University | Undergraduate Degree |
London Business School | Graduate Degree |
Statistics
International
United Kingdom | 6 |
United States | 3 |
Operational
Director/Board Member | 2 |
Founder | 2 |
Undergraduate Degree | 2 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
DeepMatter Group Plc
![]() DeepMatter Group Plc Packaged SoftwareTechnology Services DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Abaco Capital Plc
![]() Abaco Capital Plc Financial ConglomeratesFinance Abaco Capital Plc was a drug development company, which was engaged in re-developing approved drugs using proprietary formulation technologies. The company was founded by Marcelo Bravo and Nigel Theobald on October 7, 2009 and was headquartered in London, the United Kingdom. | Finance |
Oxford Pharmascience Ltd.
![]() Oxford Pharmascience Ltd. Pharmaceuticals: MajorHealth Technology Oxford Pharmascience Ltd. operates as a drug development firm. The company was founded on February 8, 2008 and is headquartered in London, the United Kingdom. | Health Technology |
OXvax Ltd
![]() OXvax Ltd BiotechnologyHealth Technology OXvax Ltd is a British company that develops cancer vaccines. The company was founded in 2021 by Paul J. Fairchild, Marcelo Leonardo Bravo, Tim Davies. Marcelo Leonardo Bravo has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Marcelo Bravo
- Experience